NorthView Acquisition (NVACR) Short Interest Ratio & Short Volume

Short interest is the volume of NorthView Acquisition shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 6,100 shares of NVACR short. Learn More on NorthView Acquisition's current short interest.

NorthView Acquisition saw a increase in short interest in June. As of June 15th, there was short interest totaling 6,100 shares, an increase of 1,425.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "medical equipment" compare to NorthView Acquisition: GE HealthCare Technologies Inc. (1.40%), Koninklijke Philips N.V. (0.32%), Zimmer Biomet Holdings, Inc. (3.25%), Smith & Nephew SNATS, Inc. (0.57%), Solventum Corporation (3.03%), Penumbra, Inc. (4.10%), Stevanato Group S.p.A. (4.74%), Glaukos Corporation (7.39%), iRhythm Technologies (8.17%), Inari Medical, Inc. (4.24%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

Short selling NVACR is an investing strategy that aims to generate trading profit from NorthView Acquisition as its price is falling. NVACR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NorthView Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVACR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVACR, twice per month. The most recent reporting period available is June, 15 2025.